Sign in
4

Changes in Ownership

Wave Life Sciences, Inc. Filed Acc 0001193125-26-047323

Chief Financial Officer sold 3,588 shares at $13.45 ($48,259)

  • Chief Financial Officer acquired 45,625 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Moran Kyle · Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-02-05 Grant or award : show line 1 in the form +45,625 137,973 D
2026-02-09 Sale : show line 2 in the form −3,588 $13.45 $48,259 134,385 D
Open-market sales · 3,588 sh · avg $13.45 · $48,259

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-02-05 Grant or award : show line 3 in the form Share Option (right to buy) +273,750 273,750 D
Loading xslF345X05/ownership.xml…